The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis

by Eleanor Drummond, Thomas Wisniewski
Published 2017-01-01

It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseases

by Geoffrey Pires, Eleanor Drummond
Published 2021-01-01

APOE-amyloid interaction: Therapeutic targets

by Thomas Wisniewski, Eleanor Drummond
Published 2020-05-01

Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies

by Geoffrey Pires, Sacha McElligott, Shiron Drusinsky, Glenda Halliday, Marie-Claude Potier, Thomas Wisniewski, Eleanor Drummond
Published 2019-12-01

Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein

by Richard Rubenstein, Binggong Chang, Natalia Grinkina, Eleanor Drummond, Peter Davies, Meir Ruditzky, Deep Sharma, Kevin Wang, Thomas Wisniewski
Published 2017-04-01

Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model

by Fernando Goñi, Mitchell Martá-Ariza, Krystal Herline, Daniel Peyser, Allal Boutajangout, Pankaj Mehta, Eleanor Drummond, Frances Prelli, Thomas Wisniewski
Published 2018-01-01